Two Sigma Advisers’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,200
| Closed | -$62.5K | – | 2475 |
|
|
2025
Q1 | $62.5K | Sell |
11,200
-55,300
| -83% | -$309K | ﹤0.01% | 2303 |
|
|
2024
Q4 | $537K | Buy |
66,500
+8,300
| +14% | +$67K | ﹤0.01% | 1748 |
|
|
2024
Q3 | $597K | Sell |
58,200
-21,900
| -27% | -$224K | ﹤0.01% | 1628 |
|
|
2024
Q2 | $566K | Buy |
80,100
+51,000
| +175% | +$361K | ﹤0.01% | 1830 |
|
|
2024
Q1 | $400K | Sell |
29,100
-2,600
| -8% | -$35.8K | ﹤0.01% | 1957 |
|
|
2023
Q4 | $292K | Buy |
31,700
+5,200
| +20% | +$47.8K | ﹤0.01% | 2109 |
|
|
2023
Q3 | $160K | Sell |
26,500
-52,500
| -66% | -$318K | ﹤0.01% | 2136 |
|
|
2023
Q2 | $613K | Buy |
79,000
+33,100
| +72% | +$257K | ﹤0.01% | 1736 |
|
|
2023
Q1 | $262K | Sell |
45,900
-9,800
| -18% | -$55.9K | ﹤0.01% | 2190 |
|
|
2022
Q4 | $328K | Sell |
55,700
-112,586
| -67% | -$663K | ﹤0.01% | 2038 |
|
|
2022
Q3 | $539K | Sell |
168,286
-96,214
| -36% | -$308K | ﹤0.01% | 1813 |
|
|
2022
Q2 | $1.19M | Buy |
264,500
+157,000
| +146% | +$703K | ﹤0.01% | 1506 |
|
|
2022
Q1 | $574K | Buy |
+107,500
| New | +$574K | ﹤0.01% | 1913 |
|